Mounjaro vs Saxenda UK
A detailed comparison between the latest weekly injection and the established daily treatment.
At a Glance: Tirzepatide vs Liraglutide
Mounjaro (Tirzepatide)
- Action: Dual GIP and GLP-1 receptor agonist
- Dosing: Once weekly injection
- Clinical Results: Up to 22.5% body weight loss
- Entry Cost: From £149/month
- Needles: Typically purchased separately
Saxenda (Liraglutide)
- Action: GLP-1 receptor agonist only
- Dosing: Once daily injection
- Clinical Results: Up to 8% body weight loss
- Entry Cost: From £49/pen
- Needles: Included with the pen
Understanding the Mechanisms
The primary distinction between these two medications lies in how they target the body's appetite regulation systems. Mounjaro is a first-in-class dual agonist. It mimics both GLP-1 and GIP hormones, which work synergistically to reduce hunger and improve how your body breaks down sugar and fat.
Saxenda, on the other hand, is an older generation treatment that solely targets the GLP-1 receptor. While it effectively delays gastric emptying and promotes a feeling of fullness, it lacks the enhanced metabolic effects provided by the GIP component found in Mounjaro.
Efficacy Deep Dive: Which Yields Better Results?
Clinical studies have demonstrated a clear difference in outcomes. Patients using Mounjaro at the highest maintenance doses achieved remarkable average weight reductions of over 20%. In contrast, Saxenda patients typically see a more modest 5-8% reduction on average.
Tirzepatide Peak
~22.5%
Average reduction in trials
Liraglutide Peak
~8.0%
Average reduction in trials
Daily vs Weekly Routine
Adherence to treatment is critical for long-term success. Mounjaro's once-weekly dosing schedule offers significant lifestyle advantages, eliminating the need to carry pens daily or schedule injections around everyday activities.
Conversely, Saxenda requires a daily commitment. While some patients seamlessly integrate this into their morning or evening routines, others experience "injection fatigue" over time. However, the short half-life of a daily injection means that if adverse reactions occur, they will typically resolve much faster upon stopping the medication compared to a weekly injection.
Financial Considerations
Pricing structures differ significantly. Saxenda allows for lower initial outlays because you can purchase a single pen (lasting roughly 17 days on the starting dose) for under £50. Mounjaro is typically sold as a 4-dose month-supply KwikPen, requiring an upfront investment of around £149 to £220 depending on the dose strength.
Final Verdict
For patients prioritizing maximum weight loss efficacy and convenience, Mounjaro represents the current gold standard in GLP-1 therapies. Saxenda remains a viable, budget-friendly entry point for those who wish to test their tolerance to these medications with a shorter-acting daily formulation.
Ready to Compare UK Prices?
Find the best deals on Mounjaro, Wegovy, and Saxenda from GPhC-registered pharmacies.